WCC 2023 | Dalian, China

Program Layout

Track 1: Cancer Diagnostics
WCC 101: Prognostic and Predictive Biomarkers
WCC 102: Next-Generation Cancer Imaging
WCC 103: Liquid Biopsies

Track 2: Anti-Cancer Drug Discovery and Development
WCC 201: New Anti-Cancer Drug Discovery, Design, and Optimization
WCC 202: Innovation and Biomarkers in Cancer Drug Development
WCC 203: Anticancer Drugs from TCM and Natural Products

Track 3: Clinical Oncology
WCC 301: Cancer of the Reproductive System
WCC 302: Breast Cancer
WCC 303: Lung Cancer/Other Thoracic Cancers
WCC 304: Cancer of Digestive System
WCC 305: Head and Neck Tumors
WCC 306: Skin Cancer
WCC 307: Hematologic Malignancies

Track 4: Cancer Therapy & Treatments
WCC 401: Cancer Targeted Therapy
WCC 402: Robotic & Surgical Therapy
WCC 403: Combination Therapy, Complementary and Alternative Medicine

Track 5: Oncology Nursing and Care
WCC 501: Cancer Rehabilitation, Cancer Nursing and Care
WCC 502: Palliative & Critical Care

Track 6: Cancer Epidemiology and Prevention
WCC 601: Cancer Epidemiology and Novel Risk and Causative Factors
WCC 602: Cancer Screening and Healthy Living

Online Registration
News Released

Speaking Proposals Are Now Being Accepted

Call for Exhibitors and Sponsors

Call for Collaborative

Honorary Chairman

Dr. Vladimir Lazar
Chief Scientific and Operating Officer WIN Consortium, France

Dr. Ashok Srivastava
Chief Executive Officer & Chief Medical Officer, ClinFomatrix, Cure Pharmaceuticals, Inc, USA

Hosting Organization
Operating Organizations
 
©2016-2023 All right reserved by BIT Congress Inc.
Tel: 0086-411-84799609, Fax: 0086-411-84796897